Health Canada releases advisory about potential risk of pulmonary illness linked to vaping products

The advisory comes as a response to recent cases of acute pulmonary illnesses

Health Canada has released an advisory about the potential risk of pulmonary illness after it has been linked to vaping products.

They suggest that Canadians who use vaping products monitor themselves for symptoms of pulmonary illness such as coughing, shortness of breath, and chest pain. If you or someone you know are experiencing these symptoms and use vaping products, Health Canada suggests you seek medical attention promptly.
 


The advisory comes as a response to recent cases of acute pulmonary illnesses, and even one death reportedly linked to vaping products in the United States. Currently, a second death is also under investigation for potentially being linked to vaping. While the Government of Canada has not seen evidence of similar pulmonary illnesses in Canada, the Public Health Agency of Canada has alerted health officials, who are urged to report possible incidents of pulmonary illness linked to vaping.

“Vaping is not without risk, and the potential long-term effects of vaping remain unknown,” Health Canada reveals in a statement. “Non-smokers, people who are pregnant and young people should not vape.”

Purchasing vaping products outside of the legal market creates additional risk for those who use vaping products, as they are unregulated.
 
Photo courtesy of Vaping 360.